Oklahoma City, OK – In a significant breakthrough that could reshape our understanding and treatment of aggressive...
London, UK – In a significant move to modernize its regulatory framework and accelerate patient access to...
An In-depth Examination of Emerging Research and Patient Considerations By Douglas Feil, NBCF Chief Program Officer In...
NEW YORK, NY — On the evening of October 13, 2026, the global skyline will undergo a...
De-Escalating Treatment: The CompassHER2-pCR Trial and the Future of Personalized Breast Cancer Care
De-Escalating Treatment: The CompassHER2-pCR Trial and the Future of Personalized Breast Cancer Care
The landscape of oncology is currently undergoing a seismic shift, moving away from the "one-size-fits-all" approach toward...
MADRID, SPAIN — As the global oncology community prepares to descend upon the historic streets of Madrid...
For over four decades, Stratton Horres lived in a world defined by the razor-thin margins of high-stakes...
As of June 2026, the landscape of the American individual health insurance market—a vital safety net for...
For decades, women undergoing mastectomy have faced a relatively narrow set of choices for breast reconstruction: saline...
By Editorial Staff The American Association of Pharmaceutical Scientists (AAPS), a professional powerhouse representing over 7,000 scientists...
